Cargando…
ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients
Severe acute respiratory syndrome coronavirus 2, the etiologic agent of coronavirus disease 2019 (COVID-19) and the cause of the current pandemic, produces multiform manifestations throughout the body, causing indiscriminate damage to multiple organ systems, particularly the lungs, heart, brain, kid...
Autores principales: | Ramos, Simone Gusmão, Rattis, Bruna Amanda da Cruz, Ottaviani, Giulia, Celes, Mara Rubia Nunes, Dias, Eliane Pedra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Investigative Pathology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099789/ https://www.ncbi.nlm.nih.gov/pubmed/33964216 http://dx.doi.org/10.1016/j.ajpath.2021.04.010 |
Ejemplares similares
-
RAAS-Blockade in COVID-19: The Ace of Spades?
por: Agarwal, Krishna A., et al.
Publicado: (2021) -
Curcumin as a Potential Treatment for COVID-19
por: Rattis, Bruna A. C., et al.
Publicado: (2021) -
RAAS, ACE2 and COVID-19; a mechanistic review
por: Elshafei, Ahmed, et al.
Publicado: (2021) -
Why Should Clinical Autopsies Continue to Exist?
por: Ramos, Simone Gusmão, et al.
Publicado: (2021) -
Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)